Trademark: 90603915
Word
KRAZATI
Status
Registered
Status Code
700
Status Date
Tuesday, April 4, 2023
Serial Number
90603915
Registration Number
7019779
Registration Date
Tuesday, April 4, 2023
Mark Type
4000
Filing Date
Thursday, March 25, 2021
Published for Opposition
Tuesday, February 22, 2022

Trademark Owner History
Mirati Therapeutics, Inc. - Original Registrant

Classifications
5 pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of infectious diseases; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma; pharmaceuticals comprising small molecules for the treatment of pancreatic cancer; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors
42 research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals

Trademark Events
Apr 4, 2023
Notice Of Registration Confirmation Emailed
Apr 4, 2023
Registered-Principal Register
Feb 28, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Feb 27, 2023
Allowed Principal Register - Sou Accepted
Feb 1, 2023
Statement Of Use Processing Complete
Jan 2, 2023
Use Amendment Filed
Jan 30, 2023
Case Assigned To Intent To Use Paralegal
Jan 2, 2023
Teas Statement Of Use Received
Oct 19, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 17, 2022
Sou Extension 1 Granted
Oct 17, 2022
Sou Extension 1 Filed
Oct 17, 2022
Teas Extension Received
Apr 19, 2022
Noa E-Mailed - Sou Required From Applicant
Feb 22, 2022
Official Gazette Publication Confirmation E-Mailed
Feb 22, 2022
Published For Opposition
Feb 2, 2022
Notification Of Notice Of Publication E-Mailed
Jan 18, 2022
Approved For Pub - Principal Register
Jan 15, 2022
Examiner's Amendment Entered
Jan 15, 2022
Notification Of Examiners Amendment E-Mailed
Jan 15, 2022
Examiners Amendment E-Mailed
Jan 15, 2022
Examiners Amendment -Written
Dec 20, 2021
Teas/Email Correspondence Entered
Dec 20, 2021
Correspondence Received In Law Office
Dec 20, 2021
Teas Response To Office Action Received
Nov 9, 2021
Assigned To Lie
Nov 8, 2021
Notification Of Non-Final Action E-Mailed
Nov 8, 2021
Non-Final Action E-Mailed
Nov 8, 2021
Non-Final Action Written
Nov 1, 2021
Assigned To Examiner
Jul 1, 2021
New Application Office Supplied Data Entered
Jun 30, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 30, 2021
Teas Change Of Correspondence Received
Jun 30, 2021
Teas Change Of Owner Address Received
Mar 29, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24